Education
About Us
Working with TipRanks
Follow Us
Biophytis (BPTSY)
OTHER OTC:BPTSY
BPTSY Stock Chart & Stats
Day’s Range― - ―
52-Week Range$2.70 - $19.58
Previous CloseN/A
Volume804.00
Average Volume (3M)1.02K
Market Cap
$4.54M
Enterprise Value$10.24M
Total Cash (Recent Filing)€5.57M
Total Debt (Recent Filing)€8.27M
Price to Earnings (P/E)―
Beta1.29
Next Earnings
Nov 04, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-15420.51
Shares Outstanding351,174
10 Day Avg. Volume22
30 Day Avg. Volume1,024
Standard Deviation0.16
R-Squared0.10
Alpha-0.15
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$15.00Price Target Upside368.75% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
---
Biophytis News
PremiumCompany Announcements
Biophytis Advances Clinical Trials and Targets $100B Market
PremiumCompany Announcements
Biophytis Advances DMD Treatment with BIO101 Scale-Up---
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
BPTSY FAQ
What was Biophytis’s price range in the past 12 months?
Biophytis lowest stock price was $2.70 and its highest was $19.58 in the past 12 months.
What is Biophytis’s market cap?
Biophytis’s market cap is $4.54M.
When is Biophytis’s upcoming earnings report date?
Biophytis’s upcoming earnings report date is Nov 04, 2025 which is in 245 days.
How were Biophytis’s earnings last quarter?
Currently, no data Available
Is Biophytis overvalued?
According to Wall Street analysts Biophytis’s price is currently Undervalued.
Does Biophytis pay dividends?
Biophytis does not currently pay dividends.
What is Biophytis’s EPS estimate?
Biophytis’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Biophytis have?
Biophytis has 351,174 shares outstanding.
What happened to Biophytis’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Biophytis?
Currently, no hedge funds are holding shares in BPTSY
---
Company Description
Biophytis
Biophytis SA is a France-based biotechnology company focused on the development of therapeutics that slow the degenerative processes associated with aging and improve functional outcomes for patients suffering from age-related diseases.
---
BPTSY Stock 12 Month Forecast
Average Price Target
$15.00
▲(368.75% Upside)
Technical Analysis
Best Analysts Covering BPTSY
1 Year
Unknown AnalystH.C. Wainwright
Not Ranked
1 Year Success Rate
0/0 ratings generated profit
1 Year Average Return
0.00%
reiterated a buy rating 19 days ago
Copying Unknown Analyst's trades and holding each position for 1 Year would result in - of your transactions generating a profit, with an average return of 0.00% per trade.
---